These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28827719)

  • 1. The risk factors of bone metastases in patients with lung cancer.
    Zhou Y; Yu QF; Peng AF; Tong WL; Liu JM; Liu ZL
    Sci Rep; 2017 Aug; 7(1):8970. PubMed ID: 28827719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-specific enolase, histopathological types, and age as risk factors for bone metastases in lung cancer.
    Zhou Y; Chen WZ; Peng AF; Tong WL; Liu JM; Liu ZL
    Tumour Biol; 2017 Jul; 39(7):1010428317714194. PubMed ID: 28671048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer.
    Huang P; Lan M; Peng AF; Yu QF; Chen WZ; Liu ZL; Liu JM; Huang SH
    PLoS One; 2017; 12(9):e0183835. PubMed ID: 28902911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metastases and skeletal-related events: incidence and prognosis according to histological subtype of lung cancer.
    Silva GT; Silva LM; Bergmann A; Thuler LC
    Future Oncol; 2019 Feb; 15(5):485-494. PubMed ID: 30624078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients.
    Song Q; Shang J; Zhang C; Zhang L; Wu X
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):737-746. PubMed ID: 30603904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study.
    Cetin K; Christiansen CF; Jacobsen JB; Nørgaard M; Sørensen HT
    Lung Cancer; 2014 Nov; 86(2):247-54. PubMed ID: 25240518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Factors and Skeletal-Related Events in Patients with Small Cell Lung Cancer with Bone Metastases at the Time of Diagnosis.
    Kang EJ; Lee SY; Kim HJ; Min KH; Hur GY; Shim JJ; Kang KH; Oh SC; Seo JH; Lee SY; Kim JS
    Oncology; 2016; 90(2):103-11. PubMed ID: 26785048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor.
    Radeczky P; Moldvay J; Fillinger J; Szeitz B; Ferencz B; Boettiger K; Rezeli M; Bogos K; Renyi-Vamos F; Hoetzenecker K; Hegedus B; Megyesfalvi Z; Dome B
    Pathol Oncol Res; 2021; 27():1609926. PubMed ID: 34629961
    [No Abstract]   [Full Text] [Related]  

  • 9. Lung cancer with bone metastases in the United States: an analysis from the Surveillance, Epidemiologic, and End Results database.
    Liu W; Wu J
    Clin Exp Metastasis; 2018 Dec; 35(8):753-761. PubMed ID: 30341554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Prognostic Factors in Bone Metastases from Lung Cancer.
    Zhang L; Gong Z
    Med Sci Monit; 2017 Aug; 23():4087-4094. PubMed ID: 28835603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and clinical impact of bone metastases in non-small cell lung cancer.
    Kuchuk M; Kuchuk I; Sabri E; Hutton B; Clemons M; Wheatley-Price P
    Lung Cancer; 2015 Aug; 89(2):197-202. PubMed ID: 26003503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for bone metastasis in completely resected non-small-cell lung cancer.
    Wang H; Zhang Y; Zhu H; Yu J
    Future Oncol; 2017 Apr; 13(8):695-704. PubMed ID: 27866423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer.
    Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
    Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.
    Hernandez RK; Wade SW; Reich A; Pirolli M; Liede A; Lyman GH
    BMC Cancer; 2018 Jan; 18(1):44. PubMed ID: 29306325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].
    Xu DL; Zhang XT; Wang GH; Li FB; Hu JY
    Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The correlation between the distant metastases and organ-specific symptoms in the patients with lung cancer].
    Alpar S; Uçar N; Turgut A; Kiratli T; Dursun BA; Kurt B
    Tuberk Toraks; 2004; 52(1):14-8. PubMed ID: 15143367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment.
    Berman AT; Thukral AD; Hwang WT; Solin LJ; Vapiwala N
    Clin Breast Cancer; 2013 Apr; 13(2):88-94. PubMed ID: 23218473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer.
    Song JW; Oh YM; Shim TS; Kim WS; Ryu JS; Choi CM
    Lung Cancer; 2009 Sep; 65(3):333-8. PubMed ID: 19144446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.
    Qiu ZL; Shen CT; Luo QY
    Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging.
    Abdel-Rahman O
    Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.